Cui, C.; Huo, Q.; Xiong, X.; Li, K.; Fishel, M.L.; Li, B.; Yokota, H.
Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmaceutics 2023, 15, 2447.
https://doi.org/10.3390/pharmaceutics15102447
AMA Style
Cui C, Huo Q, Xiong X, Li K, Fishel ML, Li B, Yokota H.
Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmaceutics. 2023; 15(10):2447.
https://doi.org/10.3390/pharmaceutics15102447
Chicago/Turabian Style
Cui, Changpeng, Qingji Huo, Xue Xiong, Kexin Li, Melissa L. Fishel, Baiyan Li, and Hiroki Yokota.
2023. "Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells" Pharmaceutics 15, no. 10: 2447.
https://doi.org/10.3390/pharmaceutics15102447
APA Style
Cui, C., Huo, Q., Xiong, X., Li, K., Fishel, M. L., Li, B., & Yokota, H.
(2023). Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmaceutics, 15(10), 2447.
https://doi.org/10.3390/pharmaceutics15102447